Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,793 public trials 1,785 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Active, not recruiting

DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]

NCT03529110

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • UCLA Hematology Oncology Los Angeles, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
View all 164 locations
View Trial Details
Active, not recruiting

A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer

NCT02107703

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • St. Bernards Medical Center Jonesboro, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California - San Diego La Jolla, California, United States
  • Kaiser Permanente Riverside, California, United States
View all 146 locations
View Trial Details
Active, not recruiting

A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

NCT04711252

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Harbor City, California, United States
  • Research Site Solvang, California, United States
View all 263 locations
View Trial Details
Active, not recruiting

Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer

NCT03289195

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Active, not recruiting

Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer

NCT01203839

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Follow-up Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Follow-up Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Follow-up Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk (Follow-up Only) Commack, New York, United States
View Trial Details
Active, not recruiting

Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)

NCT02393794

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • University of Kansas Cancer Center - Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center - West Kansas City, Kansas, United States
  • University of Kansas Cancer Center - Overland Park Overland Park, Kansas, United States
  • University of Kansas Cancer Center - Westwood Westwood, Kansas, United States
View Trial Details
Active, not recruiting

Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

NCT03734029

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Ironwood Cancer & Research Centers - Chandler II Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Cancer Treatment Centers of America at Western Regional Medical Center Goodyear, Arizona, United States
  • UCLA School of Medicine Los Angeles, California, United States
View all 208 locations
View Trial Details

Related conditions